Telomeres and telomerase in renal health

Journal of the American Society of Nephrology

Volumn 22, Issue 1, 2011, Pages 39-41

  Wills, Lauren P ^a   Schnellmann, Rick G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; CHROMOSOME SIZE; CHRONIC KIDNEY DISEASE; DISEASE COURSE; ENZYME ACTIVITY; HUMAN; KIDNEY; MITOSIS; PREVALENCE; PRIORITY JOURNAL; TELOMERE;

EID: 78651393889     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010060662     Document Type: Article

References (30)

1. Sahin E, Depinho RA: Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature 464: 520-528, 2010
2. Melk A, Halloran PF: Cell senescence and its implications for nephrology. J Am Soc Nephrol 12: 385-393, 2001
3. Zakian VA: Life and cancer without telomerase. Cell 91: 1-3, 1997
4. Orlando C, Gelmini S, Selli C, Pazzagli M: Telomerase in urological malignancy. J Urol 166: 666-673, 2001
5. Greider CW, Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43: 405-413, 1985
6. Verdun RE, Karlseder J: Replication and protection of telomeres. Nature 447: 924-931, 2007
7. Gilson E, Ségal-Bendirdjian E: The telomere story or the triumph of an open-minded research. Biochimie 92: 321-326, 2010
8. Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ, Reddel RR: Protein composition of catalytically active human telomerase from immortal cells. Science 315: 1850-1853, 2007
9. Melk A, Ramassar V, Helms LMH, Moore RON, Rayner D, Solez KIM, Halloran PF: Telomere shortening in kidneys with age. J Am Soc Nephrol 11: 444-453, 2000
10. Voghel G, Thorin-Trescases N, Mamarbachi AM, Villeneuve L, Mallette FA, Ferbeyre G, Farhat N, Perrault LP, Carrier M, Thorin E: Endogenous oxidative stress prevents telomerase-dependent immortalization of human endothelial cells. Mech Age Devel 131: 354-363, 2010
11. Zhou X, Saxena R, Liu Z, Vaziri N, Silva F: Renal senescence in 2008: progress and challenges. Int Urol Nephrol 40: 823-839, 2008
12. Westhoff JH, Schildhorn C, Jacobi C, Homme M, Hartner A, Braun H, Kryzer C, Wang C, von Zglinicki T, Kranzlin B, Gretz N, Melk A: Telomere shortening reduces regenerative capacity after acute kidney injury. J Am Soc Nephrol 21: 327-336, 2010
13. Goyal VK: Changes with age in the human kidney. Exp Gerontol 17: 321-331, 1982
14. Yang H, Fogo A: Cell sensecence and the aging kidney. J Am Soc Nephrol 21: 1436-1439, 2010
15. Anderson S, Halter JB, Hazzard WR, Himmelfarb J, Horne FM, Kaysen GA, Kusek JW, Nayfield SG, Schmader K, Tian Y, Ashworth JR, Clayton CP, Parker RP, Tarver ED, Woolard NF, High KP: Prediction, progression, and outcomes of chronic kidney disease in older adults. J Am Soc Nephrol 20: 1199-1209, 2009
16. Huzen J, de Boer RA, van Veldhuisen DJ, van Gilst WH, van der Harst P: The emerging role of telomere biology in cardiovascular disease. Front Biosci 15: 35-45, 2010
17. Vasan RS, Demissie S, Kimura M, Cupples LA, Rifai N, White C, Wang TJ, Gardner JP, Cao X, Benjamin EJ, Levy D, Aviv A: Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: The Framingham Heart Study. Circulation 117: 1138-1144, 2008
18. Peti-Peterdi J, Harris RC: Macula densa sensing and signaling mechanisms of renin release. J Am Soc Nephrol 21: 1093-1096, 2010
19. Hao CM, Haase VH: Sirtuins and their relevance to the kidney. J Am Soc Nephrol 2010
20. Baumann M, Bartholome R, Peutz-Kootstra CJ, Smits JF, Struijker-Boudier HA: Sustained tubulo-interstitial protection in SHRs by transient losartan treatment: an effect of decelerated aging? Am J Hypertens 21: 177-182, 2008
21. Andrews NP, Fujii H, Goronzy JJ, Weyand CM: Telomeres and immunological diseases of aging. Gerontology 56: 390-403, 2010
22. Weng NP: Telomere and adaptive immunity. Mech Ageing Dev 129: 60-66, 2008
23. Hogaboam CM, Steinhauser ML, Chensue SW, Kunkel SL: Novel roles for chemokines and fibroblasts in interstitial fibrosis. Kidney Int 54: 2152-2159, 1998
24. Ju Z, Rudolph KL: Telomeres and telomerase in stem cells during aging and disease. Genome Dyn 1: 84-103, 2006
25. Muller RU, Fabretti F, Zank S, Burst V, Benzing T, Schermer B: The von Hippel Lindau tumor suppressor limits longevity. J Am Soc Nephrol 20: 2513-2517, 2009
26. Finkel T, Serrano M, Blasco MA: The common biology of cancer and ageing. Nature 448: 767-774, 2007
27. Kim NW, Piatyszek MA, Prowse KB, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994
28. Epel E, Blackburn EH, Lin J, Dhabhar FS, Adler N, Morrow JD, Cawthon RM: Accelerated telomere shortening in response to life stress. Proc Nat Acad Sci USA 101: 17312-17315, 2004
29. Moon IK, Jarstfer MB: The human telomere and its relationship to human disease, therapy and tissue engineering. Front Biosci 12: 4595-4620, 2007
30. Puterman E, Lin J, Blackburn E, O'Donovan A, Adler N, Epel E: The power of exercise: Buffering the effect of chronic stress on telomere length. PLoS One 5: e10837, 2010